Exact Mass: 1268.6037
Exact Mass Matches: 1268.6037
Found 63 metabolites which its exact mass value is equals to given mass value 1268.6037
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Soyasaponin A1
Soyasaponin A1 is found in pulses. Soyasaponin A1 is isolated from soybean (Glycine max).
Goserelin
L - Antineoplastic and immunomodulating agents > L02 - Endocrine therapy > L02A - Hormones and related agents > L02AE - Gonadotropin releasing hormone analogues C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1910 - Gonadotropin-releasing Hormone Analog D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones D000970 - Antineoplastic Agents
Goserelin
Goserelin is a synthetic hormone. In men, it stops the production of the hormone testosterone, which may stimulate the growth of cancer cells. In women, goserelin decreases the production of the hormone estradiol (which may stimulate the growth of cancer cells) to levels similar to a postmenopausal state. When the medication is stopped, hormone levels return to normal. L - Antineoplastic and immunomodulating agents > L02 - Endocrine therapy > L02A - Hormones and related agents > L02AE - Gonadotropin releasing hormone analogues C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1910 - Gonadotropin-releasing Hormone Analog D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones D000970 - Antineoplastic Agents
Ioxaglic acid
V - Various > V08 - Contrast media > V08A - X-ray contrast media, iodinated > V08AB - Watersoluble, nephrotropic, low osmolar x-ray contrast media D006133 - Growth Substances > D010937 - Plant Growth Regulators > D014283 - Triiodobenzoic Acids
platycogenic acid A 3-O-beta-D-glucopyranosyl(1->6)-beta-D-glucopyranosido-28-O-beta-D-xylopyranosyl(1->4)-alpha-L-rhamnopyranosyl(1->2)-alpha-L-arabinopyranoside|platyconic acid E
3beta,20S,24S-trihydroxydammar-25-en-21,28-dioic acid 3-O-{[alpha-L-rhamnopyranosyl(1->2)][alpha-L-rhamnopyranosyl(1->6)-beta-D-glucopyranosyl(1->3)]-alpha-L-arabinopyranosyl}-21-O-beta-D-glucopyranoside
3-O-beta-D-xylopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->3)-beta-D-glucopyranosyl bayogenin-28-O-beta-D-glucopyranosyl ester|caryocaroside III-14
3beta,20S,25-trihydroxydammar-23-en-21,28-dioic acid 3-O-{[alpha-L-rhamnopyranosyl(1->2)][alpha-L-rhamnopyranosyl(1->6)-beta-D-glucopyranosyl(1->3)]-alpha-L-arabinopyranosyl}-21-O-beta-D-glucopyranoside
3-O-beta-D-glucopyranosyl (1?6)-beta-D-glucopyranosyl-28-O-beta-D-glucopyranosyl(1?6)[alpha-L-rhamnopyranosyl(1?2)]-beta-D-glucopyranosyl 16-deoxybarringtogenol C|3-O-beta-D-glucopyranosyl(1->6)-beta-D-glucopyranosyl-28-O-beta-D-glucopyranosyl(1->6)[alpha-L-rhamnopyranosyl(1->2)]-beta-D-glucopyranosyl-16-deoxy-barringtogenol C|xanifolia O54
3beta,20S,29-trihydroxydammar-24-en-21-carboxylic acid 3-O-{[alpha-L-rhamnopyranosyl-(1-2)]-[alpha-L-rhamnopyranosyl-(1-3)]-beta-D-glucopyranosyl}-21-O-[beta-D-glucopyranosyl-(1-2)]-beta-D-glucopyranoside
3-O-beta-D-xylopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->4)-beta-D-galactopyranosyl-(1->3)-beta-D-glucopyranosyl bayogenin|caryocaroside III-15
3-O-β-D-glucopyranosyl-(1?2)-β-D-glucopyranosyl-28-O-α-L-rhamnopyranosyl-(1?2)-[β-D-glucopyranosyl-(1?6)]-β-D-glucopyranosy-21β,22α-dihydroxyl-olean-12-ene
3-O-beta-D-glucopyranosyl-2beta,3beta,23-trihydroxyolean-12-en-28-oic acid-28-O-beta-D-xylopyranosyl-(1?6)-[beta-D-glucopyranosyl-(1?2)]-[beta-D-glucopyranosyl-(1?3)]-beta-D-glucopyranoside
12-O-cinnamoylsarcostin 3-O-beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranosyl-(1->4)-beta-D-oleandropyranosyl-(1->4)-beta-D-cymaropyranosyl-(1->4)-beta-D-cymaropyranoside
Actinomycin X2|isoactinomycin-X2|[B3-(4-oxo-L-proline)]-actinomycin-D
3beta,20S-dihydroxydammar-24-en-21-carboxylic acid 3-O-{[alpha-L-rhamnopyranosyl-(1-2)]-[beta-D-glucopyranosyl-(1-3)]-beta-D-glucopyranosyl}-21-O-[beta-D-glucopyranosyl-(1-2)]-beta-D-glucopyranoside
PIM3 30:0
ioxaglic acid
V - Various > V08 - Contrast media > V08A - X-ray contrast media, iodinated > V08AB - Watersoluble, nephrotropic, low osmolar x-ray contrast media D006133 - Growth Substances > D010937 - Plant Growth Regulators > D014283 - Triiodobenzoic Acids
2-amino-9-N-[(3R,6S,7R,10S,16S)-10-butan-2-yl-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3-propan-2-yl-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]-4,6-dimethyl-3-oxo-1-N-[(3R,6S,7R,10S,16S)-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]phenoxazine-1,9-dicarboxamide
H-DL-Pyr-DL-His-DL-Trp-DL-Ser-DL-Tyr-DL-Ser(tBu)-DL-Leu-Arg-DL-Pro-NHNHCONH2
2-amino-4,6-dimethyl-3-oxo-9-N-[(3R,6S,7R,10S,16S)-7,11,14-trimethyl-2,5,9,12,15,18-hexaoxo-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]-1-N-[(3R,6S,7R,10S,16S)-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]phenoxazine-1,9-dicarboxamide
Gp100 (25-33), human (TFA)
Gp100 (25-33), human TFA (Hgp100 (25-33) TFA) is the amino acids 25-33 fragment of the human melanoma antigen. It is a 9-amino acid (AA) epitope restricted by H-2Db and recognized by the T cells[1].
{3,4,5-trihydroxy-6-[(2,3,4,5-tetrahydroxypentyl)oxy]oxan-2-yl}methyl 10-[(4-{[4,5-dihydroxy-6-(hydroxymethyl)-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,5-dihydroxy-6-methyloxan-2-yl)oxy]-5-hydroxy-4a,9-bis(hydroxymethyl)-2,6a,6b,9,12a-pentamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b-dodecahydropicene-2-carboxylate
2-amino-n1-{11-hydroxy-6,13-diisopropyl-2,5,9-trimethyl-1,4,7,14,16-pentaoxo-3h,6h,9h,10h,13h,17h,18h,18ah-pyrrolo[2,1-i]1-oxa-4,7,10,13-tetraazacyclohexadecan-10-yl}-n9-{11-hydroxy-6,13-diisopropyl-2,5,9-trimethyl-1,4,7,14-tetraoxo-3h,6h,9h,10h,13h,16h,17h,18h,18ah-pyrrolo[2,1-i]1-oxa-4,7,10,13-tetraazacyclohexadecan-10-yl}-4,6-dimethyl-3-oxophenoxazine-1,9-dicarboximidic acid
n9-[(6s,9r,10s,13s,18as)-11-hydroxy-6,13-diisopropyl-2,5,9-trimethyl-1,4,7,14-tetraoxo-3h,6h,9h,10h,13h,16h,17h,18h,18ah-pyrrolo[2,1-i]1-oxa-4,7,10,13-tetraazacyclohexadecan-10-yl]-n1-[(6s,9r,10s,13s,18as)-13-[(2s)-butan-2-yl]-11-hydroxy-6-isopropyl-2,5,9-trimethyl-1,4,7,14-tetraoxo-3h,6h,9h,10h,13h,16h,17h,18h,18ah-pyrrolo[2,1-i]1-oxa-4,7,10,13-tetraazacyclohexadecan-10-yl]-2-amino-4,6-dimethyl-3-oxophenoxazine-1,9-dicarboximidic acid
(4as,6as,6br,8ar,9r,10r,11s,12ar,12br,14bs)-10-{[(2r,3r,4s,5r,6r)-4-{[(2s,3r,4r,5r,6r)-5-{[(2s,3r,4s,5s,6r)-4-{[(2s,3r,4s,5s,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}oxan-2-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-11-hydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid
3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 10-({4-[(4-{[3,5-dihydroxy-6-(hydroxymethyl)-4-[(3,4,5-trihydroxyoxan-2-yl)oxy]oxan-2-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl)oxy]-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl}oxy)-11-hydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate
11,13(18)-oleanadiene-3,16,23,28,30-pentol; (3β,16α)-form,30-carboxylic acid,3-o-[beta-d-glucopyranosyl-(1→2)-beta-d-glucopyranosyl-(1→3)-beta-d-fucopyranoside],30-o-[1-xylit-1-yl-beta-d-glucopyranos-6-yl] ester
{"Ingredient_id": "HBIN000263","Ingredient_name": "11,13(18)-oleanadiene-3,16,23,28,30-pentol; (3\u03b2,16\u03b1)-form,30-carboxylic acid,3-o-[beta-d-glucopyranosyl-(1\u21922)-beta-d-glucopyranosyl-(1\u21923)-beta-d-fucopyranoside],30-o-[1-xylit-1-yl-beta-d-glucopyranos-6-yl] ester","Alias": "NA","Ingredient_formula": "C59H96O29","Ingredient_Smile": "NA","Ingredient_weight": "0","OB_score": "NA","CAS_id": "221092-55-3","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9412","PubChem_id": "NA","DrugBank_id": "NA"}